Empyrean Technology (301269) H1 2026 earnings summary

Executive summary

• Revenue for H1 2026 reached ¥566.46 million, up 12.95% year-over-year, maintaining the top market share among domestic EDA firms.

• Net loss attributable to shareholders was ¥45.06 million, a significant decline from a net profit of ¥3.07 million in H1 2025.

• R&D investment remained high at ¥411.30 million, representing 72.61% of revenue, supporting ongoing product innovation and ecosystem expansion.

• The company continued to expand its product portfolio and achieved notable technical breakthroughs in AI-enabled EDA, 3DIC, and advanced packaging.

Financial highlights

• Operating income: ¥566.46 million, up 12.95% year-over-year.

• Net loss: ¥45.06 million, compared to a net profit of ¥3.07 million in H1 2025.

• Gross margin: 87.48%, slightly down by 1.64 percentage points year-over-year.

• Operating cash flow: -¥28.28 million, down from ¥243.21 million in H1 2025.

• R&D expenses: ¥411.30 million, up 12.59% year-over-year.

Outlook and guidance

• The company aims to maintain high R&D investment and accelerate product innovation, focusing on AI, 3DIC, and ecosystem development.

• Management expects continued market expansion and deeper penetration in advanced process nodes and digital EDA flows.